Hospital Federal dos Servidores do Estado NICHD CRS

Rio de Janeiro 20221-903

0 studies enrolling now · 11 studies all time

What they study most

HIV, HIV Infections, Pregnant Women, Tuberculosis, Zika Virus

Studies at this site

• Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants — Completed
• Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy — Completed
• Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum — Completed
• Prospective Cohort Study of HIV and Zika in Infants and Pregnancy — Completed
• Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants — Completed
• A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines — Completed
• Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection — Completed
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) — Completed
• Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children — Completed
• Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents — Completed
• Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission — Completed